Cargando…

Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma

Accumulating evidence indicates that immunotherapy helped to improve the survival and quality-of-life of patients with lung adenocarcinoma (LUAD) or lung squamous cell carcinoma (LUSC) besides chemotherapy and gene targeting treatment. This study aimed to develop immune-related gene signatures in LU...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Na, Wang, Jiahong, Zhan, Xianquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649721/ https://www.ncbi.nlm.nih.gov/pubmed/34887858 http://dx.doi.org/10.3389/fimmu.2021.752643

Ejemplares similares

Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Li, Na, et al.
Publicado: (2021)

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
por: Zhang, Wentao, et al.
Publicado: (2023)

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Zeng, Weibiao, et al.
Publicado: (2023)

A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis
por: Fan, Tao, et al.
Publicado: (2021)

Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma
por: Zhu, Jie, et al.
Publicado: (2020)

Development of a copper metabolism-related gene signature in lung adenocarcinoma
por: Chang, Wuguang, et al.
Publicado: (2022)

Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma
por: Qu, Yan, et al.
Publicado: (2020)

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis
por: Shu, Jianfeng, et al.
Publicado: (2023)

Editorial: New molecular targets involved in lung adenocarcinoma
por: Zhan, Xianquan, et al.
Publicado: (2023)

Identification of an Immune Gene Expression Signature for Predicting Lung Squamous Cell Carcinoma Prognosis
por: Yan, Yubo, et al.
Publicado: (2020)

Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma
por: Wang, Yuli, et al.
Publicado: (2022)

Label-free quantitative identification of abnormally ubiquitinated proteins as useful biomarkers for human lung squamous cell carcinomas
por: Lu, Miaolong, et al.
Publicado: (2020)

Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival
por: Chen, Rui-Lian, et al.
Publicado: (2020)

Immune- and Stemness-Related Genes Revealed by Comprehensive Analysis and Validation for Cancer Immunity and Prognosis and Its Nomogram in Lung Adenocarcinoma
por: Chen, Mengqing, et al.
Publicado: (2022)

Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation
por: Wang, Yuzhi, et al.
Publicado: (2023)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
por: Hua, Shan, et al.
Publicado: (2022)

Identification of metabolism-related gene signature in lung adenocarcinoma
por: Wang, Ning, et al.
Publicado: (2023)

Identification of an Innate Immune-Related Prognostic Signature in Early-Stage Lung Squamous Cell Carcinoma
por: Li, Liang, et al.
Publicado: (2021)

Identification of seven-gene signature for prediction of lung squamous cell carcinoma
por: Wang, Zhe, et al.
Publicado: (2019)

Identification of an immune prognostic 11-gene signature for lung adenocarcinoma
por: Yang, Tao, et al.
Publicado: (2021)

Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing
por: Yang, Jia, et al.
Publicado: (2023)

The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma
por: Gao, Jingyan, et al.
Publicado: (2022)

Comprehensive Analysis of Tumor Microenvironment Identified Prognostic Immune-Related Gene Signature in Ovarian Cancer
por: Li, Na, et al.
Publicado: (2021)

A novel zinc metabolism-related gene signature to predict prognosis and immunotherapy response in lung adenocarcinoma
por: Chang, Wuguang, et al.
Publicado: (2023)

Identification of the key genes and characterizations of Tumor Immune Microenvironment in Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC)
por: Zhang, Lemeng, et al.
Publicado: (2020)

Heart failure–related genes associated with oxidative stress and the immune landscape in lung cancer
por: Duan, Ruoshu, et al.
Publicado: (2023)

Identification of prognostically relevant gene signatures in lung squamous cell carcinoma by Lung Cancer Explorer
por: Wang, Yuqing, et al.
Publicado: (2021)

Identification of an Immune Classification and Prognostic Genes for Lung Adenocarcinoma Based on Immune Cell Signatures
por: Deng, Lili, et al.
Publicado: (2022)

Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma
por: Cao, Bingji, et al.
Publicado: (2021)

Identification of age‐ and immune‐related gene signatures for clinical outcome prediction in lung adenocarcinoma
por: Zhou, Andrew, et al.
Publicado: (2023)

A Novel M6A-Related Genes Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma
por: Wang, Xuewen, et al.
Publicado: (2022)

Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index
por: Wu, Rihan, et al.
Publicado: (2023)

Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic Adenocarcinoma
por: Zhang, Qian, et al.
Publicado: (2021)

The prognostic impact of the immune signature in head and neck squamous cell carcinoma
por: Baysal, Hasan, et al.
Publicado: (2022)

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma
por: Huang, Ziqi, et al.
Publicado: (2021)

Development and Validation of an ADME-Related Gene Signature for Survival, Treatment Outcome and Immune Cell Infiltration in Head and Neck Squamous Cell Carcinoma
por: Tang, Xinran, et al.
Publicado: (2022)

Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling
por: Lu, Chaojing, et al.
Publicado: (2016)

Systematic integration of machine learning algorithms to develop immune escape-related signatures to improve clinical outcomes in lung adenocarcinoma patients
por: Wang, Ting, et al.
Publicado: (2023)

Identification of tryptophan metabolism- and immune-related genes signature and prediction of immune infiltration landscape in bladder urothelial carcinoma
por: Zhou, Guanwen, et al.
Publicado: (2023)

Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis‐related genes
por: Diao, Xiayao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cbpp0anjn9b3io87n6bhds3kga